Personalizing Perioperative Chemotherapy in Colon Cancer
- PMID: 40765673
- PMCID: PMC12321365
- DOI: 10.1055/s-0044-1801391
Personalizing Perioperative Chemotherapy in Colon Cancer
Abstract
The traditional, surgery-first approach for colon cancer is increasingly challenged by our evolving understanding of tumor biology and a growing number of measurable tumor features that can help guide contemporary treatment plans. Certain tumor characteristics now make it practical to challenge locally advanced colon cancer with neoadjuvant chemotherapy or immunotherapy, and allow for targeted postoperative therapies. The contemporary data supporting these tailored approaches to integrating systemic therapy before or after resection are summarized in this article.
Keywords: chemotherapy; colon cancer; microsatellite instability; next-generation sequencing.
Thieme. All rights reserved.
Conflict of interest statement
Conflict of Interest None declared.
References
-
- Alonso S, Saltz L. The landmark series: chemotherapy for non-metastatic colon cancer. Ann Surg Oncol. 2021;28(02):995–1001. - PubMed
-
- Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators . André T, Boni C, Mounedji-Boudiaf L et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004;350(23):2343–2351. - PubMed
Publication types
LinkOut - more resources
Full Text Sources